Cargando…
Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer
Maximum standard uptake value (SUVmax) of F-18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) is reportedly useful for evaluating regional lymph nodes (RLNs) of non-small-cell lung cancer (NSCLC) to predict malignancy. However, it is difficult for clinicians to meas...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039694/ https://www.ncbi.nlm.nih.gov/pubmed/29952981 http://dx.doi.org/10.1097/MD.0000000000011226 |
_version_ | 1783338725483216896 |
---|---|
author | Takeda, Yuichiro Miura, Keita Sato, Teruhiko Tsujimoto, Yoshie Nagano, Naoko Nagasaka, Satoshi Kina, Satsuki Sugiyama, Haruhito |
author_facet | Takeda, Yuichiro Miura, Keita Sato, Teruhiko Tsujimoto, Yoshie Nagano, Naoko Nagasaka, Satoshi Kina, Satsuki Sugiyama, Haruhito |
author_sort | Takeda, Yuichiro |
collection | PubMed |
description | Maximum standard uptake value (SUVmax) of F-18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) is reportedly useful for evaluating regional lymph nodes (RLNs) of non-small-cell lung cancer (NSCLC) to predict malignancy. However, it is difficult for clinicians to measure SUVmax (mSUVmax) as calculated by a workstation. We assessed the utility of simplified SUVmax (sSUVmax) in screening RLNs for pathologic malignancy. The highest color was visually defined in the region of interest. The resulting color can be quantified using the color bar, and interpreted as sSUVmax. Patients in respiratory medicine and surgery who underwent both contrast-enhanced CT and FDG-PET/CT within 3 months before radical lobectomy were evaluated retrospectively. The correlation was examined by regression analysis and receiver operating characteristic (ROC) curve analyses. Participants comprised 69 patients with NSCLC treated between May 2009 and April 2016. Medical group comprised 22 patients from respiratory medicine. The prediction model could be written as a linear relationship (mSUVmax = 1.019 × sSUVmax; R(2) = 0.930). A total of 316 RLNs resected by surgery in total cohort were pathologically determined. From ROC curves, area under curve for sSUVmax was 0.72 (95% confidence interval, 0.61–0.83; P < .0002). The cutoff sSUVmax was 2.42 (sensitivity, 52%; specificity, 88%; accuracy, 85%). The sSUVmax allows quantification of colors from FDG-PET/CT and shows a close correlation to mSUVmax. This value may have potential in screening for RLNs, and thoracic clinicians can readily determine the value. These findings may facilitate better planning of therapeutic strategy in the real world. |
format | Online Article Text |
id | pubmed-6039694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-60396942018-07-16 Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer Takeda, Yuichiro Miura, Keita Sato, Teruhiko Tsujimoto, Yoshie Nagano, Naoko Nagasaka, Satoshi Kina, Satsuki Sugiyama, Haruhito Medicine (Baltimore) Research Article Maximum standard uptake value (SUVmax) of F-18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) is reportedly useful for evaluating regional lymph nodes (RLNs) of non-small-cell lung cancer (NSCLC) to predict malignancy. However, it is difficult for clinicians to measure SUVmax (mSUVmax) as calculated by a workstation. We assessed the utility of simplified SUVmax (sSUVmax) in screening RLNs for pathologic malignancy. The highest color was visually defined in the region of interest. The resulting color can be quantified using the color bar, and interpreted as sSUVmax. Patients in respiratory medicine and surgery who underwent both contrast-enhanced CT and FDG-PET/CT within 3 months before radical lobectomy were evaluated retrospectively. The correlation was examined by regression analysis and receiver operating characteristic (ROC) curve analyses. Participants comprised 69 patients with NSCLC treated between May 2009 and April 2016. Medical group comprised 22 patients from respiratory medicine. The prediction model could be written as a linear relationship (mSUVmax = 1.019 × sSUVmax; R(2) = 0.930). A total of 316 RLNs resected by surgery in total cohort were pathologically determined. From ROC curves, area under curve for sSUVmax was 0.72 (95% confidence interval, 0.61–0.83; P < .0002). The cutoff sSUVmax was 2.42 (sensitivity, 52%; specificity, 88%; accuracy, 85%). The sSUVmax allows quantification of colors from FDG-PET/CT and shows a close correlation to mSUVmax. This value may have potential in screening for RLNs, and thoracic clinicians can readily determine the value. These findings may facilitate better planning of therapeutic strategy in the real world. Wolters Kluwer Health 2018-06-29 /pmc/articles/PMC6039694/ /pubmed/29952981 http://dx.doi.org/10.1097/MD.0000000000011226 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Research Article Takeda, Yuichiro Miura, Keita Sato, Teruhiko Tsujimoto, Yoshie Nagano, Naoko Nagasaka, Satoshi Kina, Satsuki Sugiyama, Haruhito Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer |
title | Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer |
title_full | Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer |
title_fullStr | Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer |
title_full_unstemmed | Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer |
title_short | Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer |
title_sort | clinically simplified screening methods to evaluate maximum standard uptake value from f-18-fdg-pet/ct in patients with non-small-cell lung cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039694/ https://www.ncbi.nlm.nih.gov/pubmed/29952981 http://dx.doi.org/10.1097/MD.0000000000011226 |
work_keys_str_mv | AT takedayuichiro clinicallysimplifiedscreeningmethodstoevaluatemaximumstandarduptakevaluefromf18fdgpetctinpatientswithnonsmallcelllungcancer AT miurakeita clinicallysimplifiedscreeningmethodstoevaluatemaximumstandarduptakevaluefromf18fdgpetctinpatientswithnonsmallcelllungcancer AT satoteruhiko clinicallysimplifiedscreeningmethodstoevaluatemaximumstandarduptakevaluefromf18fdgpetctinpatientswithnonsmallcelllungcancer AT tsujimotoyoshie clinicallysimplifiedscreeningmethodstoevaluatemaximumstandarduptakevaluefromf18fdgpetctinpatientswithnonsmallcelllungcancer AT naganonaoko clinicallysimplifiedscreeningmethodstoevaluatemaximumstandarduptakevaluefromf18fdgpetctinpatientswithnonsmallcelllungcancer AT nagasakasatoshi clinicallysimplifiedscreeningmethodstoevaluatemaximumstandarduptakevaluefromf18fdgpetctinpatientswithnonsmallcelllungcancer AT kinasatsuki clinicallysimplifiedscreeningmethodstoevaluatemaximumstandarduptakevaluefromf18fdgpetctinpatientswithnonsmallcelllungcancer AT sugiyamaharuhito clinicallysimplifiedscreeningmethodstoevaluatemaximumstandarduptakevaluefromf18fdgpetctinpatientswithnonsmallcelllungcancer |